Effect of G17DT in Patients With Stage II/III Colorectal Cancer
Status:
Completed
Trial end date:
2001-02-01
Target enrollment:
Participant gender:
Summary
This Phase 2 study was an open label, single-center 18-week study to compare basal and meal
stimulated plasma gastrin levels before and after treatment with 3 intramuscular injections
of 250 µg G17DT, with and without the concomitant administration of Omeprazole.